Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The use of the orthotopic model to validate antivascular therapies for cancer.
Loi M, Di Paolo D, Becherini P, Zorzoli A, Perri P, Carosio R, Cilli M, Ribatti D, Brignole C, Pagnan G, Ponzoni M, Pastorino F. Loi M, et al. Among authors: di paolo d. Int J Dev Biol. 2011;55(4-5):547-55. doi: 10.1387/ijdb.103230ml. Int J Dev Biol. 2011. PMID: 21858775 Free article. Review.
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.
Pastorino F, Di Paolo D, Loi M, Becherini P, Caffa I, Zorzoli A, Marimpietri D, Carosio R, Perri P, Montaldo PG, Brignole C, Pagnan G, Ribatti D, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: di paolo d. Curr Drug Targets. 2009 Oct;10(10):1021-7. doi: 10.2174/138945009789577954. Curr Drug Targets. 2009. PMID: 19663770 Review.
Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
Pastorino F, Brignole C, Di Paolo D, Nico B, Pezzolo A, Marimpietri D, Pagnan G, Piccardi F, Cilli M, Longhi R, Ribatti D, Corti A, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: di paolo d. Cancer Res. 2006 Oct 15;66(20):10073-82. doi: 10.1158/0008-5472.CAN-06-2117. Cancer Res. 2006. PMID: 17047071 Free article.
Ligand-targeted liposomal therapies of neuroblastoma.
Pastorino F, Marimpietri D, Brignole C, Di Paolo D, Pagnan G, Daga A, Piccardi F, Cilli M, Allen TM, Ponzoni M. Pastorino F, et al. Among authors: di paolo d. Curr Med Chem. 2007;14(29):3070-8. doi: 10.2174/092986707782793916. Curr Med Chem. 2007. PMID: 18220743 Review.
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
Pagnan G, Di Paolo D, Carosio R, Pastorino F, Marimpietri D, Brignole C, Pezzolo A, Loi M, Galietta LJ, Piccardi F, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M. Pagnan G, et al. Among authors: di paolo d. Clin Cancer Res. 2009 Feb 15;15(4):1199-209. doi: 10.1158/1078-0432.CCR-08-2477. Clin Cancer Res. 2009. PMID: 19228726
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.
Loi M, Becherini P, Emionite L, Giacomini A, Cossu I, Destefanis E, Brignole C, Di Paolo D, Piaggio F, Perri P, Cilli M, Pastorino F, Ponzoni M. Loi M, et al. Among authors: di paolo d. J Control Release. 2014 Oct 28;192:157-66. doi: 10.1016/j.jconrel.2014.07.009. Epub 2014 Jul 17. J Control Release. 2014. PMID: 25041999
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
Brignole C, Marimpietri D, Pastorino F, Nico B, Di Paolo D, Cioni M, Piccardi F, Cilli M, Pezzolo A, Corrias MV, Pistoia V, Ribatti D, Pagnan G, Ponzoni M. Brignole C, et al. Among authors: di paolo d. J Natl Cancer Inst. 2006 Aug 16;98(16):1142-57. doi: 10.1093/jnci/djj309. J Natl Cancer Inst. 2006. PMID: 16912267
95 results